Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)

Free Medical Books

  Cervical Cancer

  Free Subscription


Articles published in Gynecol Oncol

Retrieve available abstracts of 243 articles:
HTML format
Text format



Single Articles


    May 2012
  1. KUO SH , Chou CH, Cheng AL, Wang CW, et al
    Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-kappaB-dependent cyclin D1 signaling.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. CHANG SJ , Ryu HS, Nam JH
    Uterine artery-preserving laparoscopic radical trachelectomy for early cervical cancer: Technical aspects.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. DINKELSPIEL H , Fetterman B, Poitras N, Kinney W, et al
    Screening history preceding a diagnosis of cervical cancer in women age 65 and older.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    April 2012
  4. TOITA T , Kitagawa R, Hamano T, Umayahara K, et al
    Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: Efficacy and toxicity of a low cumulative radiation dose schedules.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. FRUSCIO R , Villa A, Chiari S, Vergani P, et al
    Delivery Delay with Neoadjuvant Chemotherapy for Cervical Cancer Patients during Pregnancy: A Series of Nine Cases and Literature Review.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. CHANG SJ , Bristow RE, Ryu HS
    A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  7. ZAGOURI F , Sergentanis TN, Chrysikos D, Filipits M, et al
    Molecularly targeted therapies in cervical cancer. A systematic review.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  8. PALAIA I , Musella A, Bellati F, Marchetti C, et al
    Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  9. JIN L , Shen Q, Ding S, Jiang W, et al
    Immunohistochemical Expression of Annexin A2 and S100A Proteins in Patients with Bulky stage IB-IIA Cervical Cancer Treated with Neoadjuvant Chemotherapy.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  10. ZIEBARTH AJ , Smith H, Killian ME, Nguyen NA, et al
    Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  11. DE FREITAS AC , Gurgel AP, Amaral CM, Coimbra EC, et al
    Susceptibility to cervical cancer: An overview.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    March 2012
  12. BILIATIS I , Kucukmetin A, Patel A, Ratnavelu N, et al
    Small volume stage 1B1 cervical cancer: Is radical surgery still necessary?
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  13. YAVAS G , Yavas C
    Comment on "quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study" by Ferrandina et al. (GYNECOL ONCOL 2012; 124:389-394).
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles   



  14. KIM CH , Abu-Rustum NR, Chi DS, Gardner GJ, et al
    Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  15. SCHMIDT AM , Imesch P, Fink D, Egger H, et al
    Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  16. BODELON C , Madeleine MM, Johnson LG, Du Q, et al
    Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.
    Gynecol Oncol. 2012;124:525-8.
    PubMed     Text format     Related articles    Abstract available



    February 2012
  17. MACDOUGALL DS , Connor UM, Johnstone PA
    Comprehensibility of Patient Consent Forms for Radiation Therapy of Cervical Cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  18. HOCKEL M
    Comment on: Response to the Letter to the Editor by M. Hockel et al: Laterally extended parametrectomy in node-positive early stage cervical cancer: Right direction, wrong track, by L. Ungar, Z. Novak, and L. Palfalvi.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles   



  19. PENG X , Wu Z, Yu L, Li J, et al
    Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  20. UNGAR L , Novak Z, Palfalvi L
    Response to the Letter to the Editor by M. Hoeckel et al.: Laterally extended parametrectomy in node-positive, early-stage cervical cancer: Right direction in the wrong way.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles   



  21. GIL-MORENO A , Magrina JF, Perez-Benavente A, Diaz-Feijoo B, et al
    Location of aortic node metastases in locally advanced cervical cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  22. KITAGAWA R , Katsumata N, Ando M, Shimizu C, et al
    A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  23. ULMER H , Bjorge T, Concin H, Lukanova A, et al
    Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  24. ZHOU J , Peng C, Li B, Wang F, et al
    Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.
    Gynecol Oncol. 2012;124:296-302.
    PubMed     Text format     Related articles    Abstract available



  25. BAANDRUP L , Munk C, Andersen KK, Junge J, et al
    HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.
    Gynecol Oncol. 2012;124:281-5.
    PubMed     Text format     Related articles    Abstract available



    January 2012
  26. CHASE DM , Huang HQ, Wenzel L, Cella D, et al
    Quality of Life and Survival in Advanced Cervical Cancer: A Gynecologic Oncology Group Study.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  27. GYLLENSTEN U , Gustavsson I, Lindell M, Wilander E, et al
    Primary high-risk HPV screening for cervical cancer in post-menopausal women.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  28. KATANYOO K , Sanguanrungsirikul S, Manusirivithaya S
    Comparison of Treatment Outcomes between Squamous Cell Carcinoma and Adenocarcinoma in Locally Advanced Cervical Cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  29. GALIC V , Herzog TJ, Lewin SN, Neugut AI, et al
    Prognostic Significance of Adenocarcinoma Histology in Women with Cervical Cancer.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  30. MONSONEGO J , Hudgens MG, Zerat L, Zerat JC, et al
    Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  31. VAN HANEGEM N , Barroilhet LM, Nucci MR, Bernstein M, et al
    Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
    Gynecol Oncol. 2012;124:72-7.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  32. HOCKEL M , Horn LC, Einenkel J
    Laterally extended parametrectomy in nodal positive early stage cervical cancer: Right direction on an improper way.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  33. DU XL , Tao J, Sheng XG, Lu CH, et al
    Intensity-modulated radiation therapy for advanced cervical cancer: An comparison of dosimetric and clinical outcomes with conventional radiotherapy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  34. ROSE PG , Sill MW, McMeekin DS, Ahmed A, et al
    A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy with Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: A Gynecologic Oncology Group Study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. HOCKEL M , Horn LC, Tetsch E, Einenkel J, et al
    Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. WOLFSON AH , Varia MA, Moore D, Rao GG, et al
    ACR Appropriateness Criteria(R) role of adjuvant therapy in the management of early stage cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  37. COSTA S , Venturoli S, Negri G, Sideri M, et al
    Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: An analysis of 166 cases.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  38. MA J , Zhu Q, Han S, Zhang Y, et al
    Effect of Socio-Economic Factors on Delayed Access to Health Care among Chinese Cervical Cancer Patients with Late Rectal Complications after Radiotherapy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  39. CIBULA D , Abu-Rustum NR, Dusek L, Zikan M, et al
    Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  40. ALEMANY L , Perez C, Tous S, Llombart-Bosch A, et al
    Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  41. LOUWERS JA , Berkhof J, Zaal A, Kocken M, et al
    HrHPV-testing in a university hospital gynecology outpatient clinic: Recommendations for clinical practice.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  42. JIANG J , Zhao LJ, Zhao C, Zhang G, et al
    Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  43. SHIN SJ , Kim KR, Song DE, Ro JY, et al
    Recognition of parametrial invasion, an important landmark when treating cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  44. BOREN TP , Carrick K, Kehoe SM, Lea J, et al
    Correlation of cone biopsy with findings at radical hysterectomy and use of adjuvant radiation therapy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  45. EINSTEIN MH , Rash JK, Chappell RJ, Swietlik JM, et al
    Quality of life in cervical cancer survivors: Patient and provider perspectives on common complications of cervical cancer and treatment.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  46. MAHMUD SM , Sangwa-Lugoma G, Nasr SH, Kayembe PK, et al
    COMPARISON of Human Papillomavirus Testing and Cytology for Cervical Cancer Screening in a Primary Health Care Setting in the Democratic Republic of Congo.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  47. CHAUDARY N , Milosevic M, Hill RP
    Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
    Gynecol Oncol. 2011;123:393-400.
    PubMed     Text format     Related articles    Abstract available



  48. GOUY S , Kane A, Uzan C, Gauthier T, et al
    Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy: about fourteen consecutive cases.
    Gynecol Oncol. 2011;123:329-32.
    PubMed     Text format     Related articles    Abstract available



  49. CHAGAS BS , Batista MV, Guimaraes V, Balbino VQ, et al
    New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil.
    Gynecol Oncol. 2011;123:284-8.
    PubMed     Text format     Related articles    Abstract available



  50. NICOL AF , Monsonego J
    Summary of the Eurogin 2011 conference: Highlighting the recent advances in HPV-related cancers.
    Gynecol Oncol. 2011;123:179-81.
    PubMed     Text format     Related articles   



    October 2011
  51. HORN LC , Kellner C, Scherling R, Hockel M, et al
    Ultrastaging for micrometastases in para-aortic lymph nodes in patients with carcinoma of the uterine cervix.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  52. FERRANDINA G , Mantegna G, Petrillo M, Fuoco G, et al
    Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  53. NICK AM , Frumovitz MM, Soliman PT, Schmeler KM, et al
    Fertility sparing surgery for treatment of early-stage cervical cancer: Open vs. robotic radical trachelectomy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  54. LI Y , Wang W, Wang W, Yang R, et al
    Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  55. LEE YY , Choi CH, Sung CO, Do IG, et al
    Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  56. SMRKOLJ S , Pogacnik RK, Slabe N, Rakar S, et al
    Clinical outcome of patients with FIGO stage IA2 squamous cell carcinoma of the uterine cervix.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  57. SONG S , Song C, Kim HJ, Wu HG, et al
    20year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: Impact of treatment period and concurrent chemotherapy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  58. ZHANG X , Dai B, Zhang B, Wang Z, et al
    Vitamin A and risk of cervical cancer: A meta-analysis.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  59. ROSSI EC , Ivanova A, Boggess JF
    Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  60. HAZEWINKEL MH , Gietelink L, van der Velden J, Burger MP, et al
    Renal ultrasound to detect hydronephrosis: A need for routine imaging after radical hysterectomy?
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  61. BRISTOW RE
    "Kegel ball" induced vaginal cuff dehiscence following radical abdominal hysterectomy: Laparoscopically-assisted transvaginal retrieval.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  62. ELSAHWI KS , Barber E, Illuzzi J, Buza N, et al
    The significance of perineural invasion in early-stage cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  63. HELPMAN L , Grisaru D, Covens A
    Early adenocarcinoma of the cervix: is radical vaginal trachelectomy safe?
    Gynecol Oncol. 2011;123:95-8.
    PubMed     Text format     Related articles    Abstract available



  64. VAN DER MEIDE WF , Snellenberg S, Meijer CJ, Baalbergen A, et al
    Promoter methylation analysis of WNT/beta-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
    Gynecol Oncol. 2011;123:116-22.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  65. SEAMON LG , Tarrant RL, Fleming ST, Vanderpool RC, et al
    Cervical cancer survival for patients referred to a tertiary care center in Kentucky.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  66. KATANYOO K , Tangjitgamol S, Chongthanakorn M, Tantivatana T, et al
    Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. TOMITA N , Toita T, Kodaira T, Shinoda A, et al
    Changing trend in the patterns of pretreatment diagnostic assessment for patients with cervical cancer in Japan.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  68. MAZUMDER INDRA D , Singh RK, Mitra S, Dutta S, et al
    Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  69. MANEO A , Sideri M, Scambia G, Boveri S, et al
    Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  70. NGO C , Alran S, Plancher C, Fourchotte V, et al
    Outcome in early cervical cancer following pre-operative low dose rate brachytherapy: A ten-year follow up of 257 patients treated at a single institution.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  71. BATS AS , Buenerd A, Querleu D, Leblanc E, et al
    Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: A prospective, multicenter study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  72. SOLIMAN PT , Frumovitz M, Sun CC, Dos Reis R, et al
    Radical hysterectomy: A comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  73. SIGNORELLI M , Guerra L, Montanelli L, Crivellaro C, et al
    Preoperative staging of cervical cancer: Is 18-FDG-PET/CT really effective in patients with early stage disease?
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  74. TROPE A , Jonassen CM, Sjoborg KD, Nygard M, et al
    Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  75. OVESTAD IT , Vennestrom U, Andersen L, Gudlaugsson E, et al
    Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  76. ZHANG Z , Knobloch TJ, Seamon LG, Stoner GD, et al
    A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  77. MABUCHI S , Okazawa M, Isohashi F, Matsuo K, et al
    Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  78. PLANTE M , Smith EB, Cox S, Silverberg K, et al
    The case of a viable pregnancy post vaginal radical trachelectomy followed by combined chemo-radiation therapy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  79. UNGAR L , Palfalvi L, Tarnai L, Horanyi D, et al
    Surgical treatment of lymph node metastases in stage IB cervical cancer. The laterally extended parametrectomy (LEP) procedure: Experience with a 5year follow-up.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  80. LINDSTROM AK , Asplund A, Hellberg D
    Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium.
    Gynecol Oncol. 2011;122:372-6.
    PubMed     Text format     Related articles    Abstract available



  81. KOCKEN M , Baalbergen A, Snijders PJ, Bulten J, et al
    High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix.
    Gynecol Oncol. 2011;122:297-302.
    PubMed     Text format     Related articles    Abstract available



  82. ZHAO C , Chen X, Onisko A, Kanbour A, et al
    Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.
    Gynecol Oncol. 2011;122:291-6.
    PubMed     Text format     Related articles    Abstract available



  83. ROY M , Bouchard-Fortier G, Popa I, Gregoire J, et al
    Value of sentinel node mapping in cancer of the cervix.
    Gynecol Oncol. 2011;122:269-74.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  84. HO KC , Wang CC, Qiu JT, Lai CH, et al
    Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  85. ZOU H , Wang D, Gan X, Jiang L, et al
    Low TWEAK expression is correlated to the progression of squamous cervical carcinoma.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  86. YEO RM , Chia YN, Namuduri RP, Yap SP, et al
    Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  87. LEVY A , Caramella C, Chargari C, Medjhoul A, et al
    Accuracy of Diffusion-Weighted Echo-Planar MR Imaging and ADC Mapping in the evaluation of residual Cervical Carcinoma after radiation therapy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  88. ROSE PG , Ali S
    Commentary on "Is there a real standard for stage IVa cervical cancer?"
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  89. YING X , Li-Zhi L, Li-Ping C, Min Z, et al
    Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  90. ZAND B , Ramirez PT
    Re: "Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer"
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  91. SYMONDS RP , Davidson SE, Chan S, Reed NS, et al
    SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  92. KRUSE AJ , van Gorp T, Van de Vijver KK
    Re: Post-coital vaginal douching is risky for non-regression of low-grade squamous intraepithelial lesion of the cervix.
    Gynecol Oncol. 2011;122:202-3.
    PubMed     Text format     Related articles   



    June 2011
  93. ORR JM , Barnett JC, Leath CA 3rd
    Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  94. HENRIQUEZ-HERNANDEZ LA , Lloret M, Pinar B, Bordon E, et al
    BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  95. KODAMA J , Kusumoto T, Nakamura K, Seki N, et al
    Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  96. SANTIN AD , Sill MW, McMeekin DS, Leitao MM Jr, et al
    Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  97. BELLATI F , Gasparri ML, Benedetti Panici P
    Is There a Real Standard For Stage IVa Cervical Cancer?
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  98. VAZQUEZ-ULLOA E , Lizano M, Aviles-Salas A, Alfaro-Moreno E, et al
    Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  99. VALARI O , Koliopoulos G, Karakitsos P, Valasoulis G, et al
    Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: Predictors and clinical implications.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  100. CHOI JJ , Buttrick S, Zakashansky K, Nezhat F, et al
    Laparoscopic adrenalectomy for isolated adrenal metastasis from cervical squamous cell carcinoma and endometrial adenocarcinoma.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  101. POLTERAUER S , Hofstetter G, Grimm C, Rahhal J, et al
    Relevance of gamma-glutamyltransferase - a marker for apoptotic balance - in predicting tumor stage and prognosis in cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  102. DOWNS L
    Advances in cervical cancer treatment.
    Gynecol Oncol. 2011;121:431-3.
    PubMed     Text format     Related articles   



  103. MIAO J , Fleury AC, Kushnir CL, Silver DF, et al
    Post fellowship training in "new-to-them" surgical techniques: assessment of learning curve characteristics.
    Gynecol Oncol. 2011;121:620-4.
    PubMed     Text format     Related articles    Abstract available



  104. GRIMM C , Watrowski R, Baumuhlner K, Natter C, et al
    Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia.
    Gynecol Oncol. 2011;121:537-41.
    PubMed     Text format     Related articles    Abstract available



  105. KUPETS R , Paszat L
    How are women with high grade Pap smear abnormalities managed? A population based study.
    Gynecol Oncol. 2011;121:499-504.
    PubMed     Text format     Related articles    Abstract available



  106. LI J , Li Z, Wang H, Zang R, et al
    Radical abdominal trachelectomy for cervical malignancies: surgical, oncological and fertility outcomes in 62 patients.
    Gynecol Oncol. 2011;121:565-70.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  107. MARCHIOLE P , Tigaud JD, Costantini S, Mammoliti S, et al
    Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB-IIA1).
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  108. DEL PINO M , Rodriguez-Carunchio L, Alonso I, Torne A, et al
    Clinical, colposcopic and pathological characteristics of cervical and vaginal high-grade lesions negative for HPV by Hybrid Capture 2.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  109. CHEREAU E , Ballester M, Darai E
    Re: <<Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer>>
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  110. LEVINSON KL , Bristow RE, Donohue PK, Kanarek NF, et al
    Impact of payer status on treatment of cervical cancer at a tertiary referral center.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  111. LIU J , Wang X, Zhou G, Wang H, et al
    Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  112. CORMIER B , Diaz JP, Shih K, Sampson RM, et al
    Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  113. MANCI N , Marchetti C, Di Tucci C, Giorgini M, et al
    A prospective phase II study of topotecan (Hycamtin(R)) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  114. JUKO-PECIREP I , Ivansson EL, Gyllensten UB
    Evaluation of Fanconi anaemia genes FANCA, FANCC and FANCL in cervical cancer susceptibility.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  115. LANOWSKA M , Morawietz L, Sikora A, Raber G, et al
    Prevalence of lymph nodes in the parametrium of radical vaginal trachelectomy (RVT) specimen.
    Gynecol Oncol. 2011;121:298-302.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  116. YUE C , Wang M, Ding B, Wang W, et al
    Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  117. CHEN CC , Lin JC, Jan JS, Ho SC, et al
    Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  118. MABUCHI S , Matsumoto Y, Isohashi F, Yoshioka Y, et al
    Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  119. LIU Y , Liu H, Bai X, Ye Z, et al
    Differentiation of metastatic from non-metastatic lymph nodes in patients with uterine cervical cancer using diffusion-weighted imaging.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  120. SUN C , Reimers LL, Burk RD
    Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
    Gynecol Oncol. 2011;121:59-63.
    PubMed     Text format     Related articles    Abstract available



  121. VALASOULIS G , Koliopoulos G, Founta C, Kyrgiou M, et al
    Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia.
    Gynecol Oncol. 2011;121:43-8.
    PubMed     Text format     Related articles    Abstract available



  122. INCE U , Aydin O, Peker O
    Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL
    Gynecol Oncol. 2011;121:152-6.
    PubMed     Text format     Related articles    Abstract available



  123. TSOUMPOU I , Valasoulis G, Founta C, Kyrgiou M, et al
    High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Gynecol Oncol. 2011;121:49-53.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  124. CORRENTI M , Medina F, Cavazza ME, Rennola A, et al
    Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  125. PETRY KU , Schmidt D, Scherbring S, Luyten A, et al
    Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  126. ROSE PG , Ali S, Whitney CW, Lanciano R, et al
    Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  127. MAGRINA JF , Pawlina W, Kho RM, Magtibay PM, et al
    Robotic nerve-sparing radical hysterectomy: Feasibility and technique.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  128. OSANN K , Wenzel L, Dogan A, Hsieh S, et al
    Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  129. SIDERI M , Igidbashian S, Boveri S, Radice D, et al
    Age distribution of HPV genotypes in cervical intraepithelial neoplasia.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  130. ERFANI N , Ghaderi A
    ctla-4 gene variations in southern Iranian patients with cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  131. SCHMELER KM , Frumovitz M, Ramirez PT
    Conservative management of early stage cervical cancer: Is there a role for less radical surgery?
    Gynecol Oncol. 2011;120:321-5.
    PubMed     Text format     Related articles    Abstract available



  132. ZANVETTOR PH , Filho DF, Neves AR, Amorim MJ, et al
    Laparoscopic surgical staging of locally advanced cervix cancer (IB2 to IVA): initial experience.
    Gynecol Oncol. 2011;120:358-61.
    PubMed     Text format     Related articles    Abstract available



  133. CHU TY , Hsiung CA, Chen CA, Chou HH, et al
    Post-coital vaginal douching is risky for non-regression of low-grade squamous intraepithelial lesion of the cervix.
    Gynecol Oncol. 2011;120:449-53.
    PubMed     Text format     Related articles    Abstract available



  134. EMBRY JR , Kelly MG, Post MD, Spillman MA, et al
    Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy.
    Gynecol Oncol. 2011;120:444-8.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  135. SERT MB , Abeler V
    Robot-assisted laparoscopic radical hysterectomy: Comparison with total laparoscopic hysterectomy and abdominal radical hysterectomy; one surgeon's experience at the Norwegian Radium Hospital.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  136. ALSBEIH G , Ahmed R, Al-Harbi N, Venturina LA, et al
    Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  137. MARTINEZ A , Mery E, Querleu D
    Response to micrometastases in para-aortic lymph nodes in advanced cervical cancer patients are a true predictor of recurrence at this level?
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  138. KIM HS , Kim JH, Chung HH, Kim HJ, et al
    Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  139. CAPRI S , Gasparini R, Panatto D, Demarteau N, et al
    Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  140. KANG WD , Kim CH, Cho MK, Kim JW, et al
    HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  141. FARLEY J , Sill MW, Birrer M, Walker J, et al
    Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  142. KATSAROS D , Gribaudo S
    The proper use of multimodality treatment in locally advanced cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  143. DOWNS LS JR , Chura JC, Argenta PA, Judson PL, et al
    Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.
    Gynecol Oncol. 2011;120:265-9.
    PubMed     Text format     Related articles    Abstract available



  144. EIJSINK JJ , Yang N, Lendvai A, Klip HG, et al
    Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study.
    Gynecol Oncol. 2011;120:280-3.
    PubMed     Text format     Related articles    Abstract available



  145. AN HJ , Sung JM, Park AR, Song KJ, et al
    Prospective evaluation of longitudinal changes in human papillomavirus genotype and phylogenetic clade associated with cervical disease progression.
    Gynecol Oncol. 2011;120:284-90.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  146. PANICI PB , Di Donato V, Plotti F, Musella A, et al
    Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  147. MANDAL RK , Mittal RD
    "Letter to editor" in lieu of article published below in Gynecol Oncolo. 2010 Oct;119(1):136-9 ctla-4 gene variations may influence cervical cancer susceptibility.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  148. SIOUTAS A , Schedvins K, Larson B, Gemzell-Danielsson K, et al
    Three cases of vaginal radical trachelectomy during pregnancy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



  149. KINNEY W , Fetterman B, Cox JT, Lorey T, et al
    Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  150. GARG G , Shah JP, Toy EP, Field JB, et al
    Intra-operative detection of nodal metastasis in early stage cervical cancer: A survey of the practice patterns of SGO members.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  151. PLANTE M , Gregoire J, Renaud MC, Roy M, et al
    The vaginal radical trachelectomy: An update of a series of 125 cases and 106 pregnancies.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  152. KRUIJDENBERG CB , van den Einden LC, Hendriks JC, Zusterzeel PL, et al
    Robot-assisted versus total laparoscopic radical hysterectomy in early cervical cancer, a review.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  153. DIAZ JP , Gemignani ML, Pandit-Taskar N, Park KJ, et al
    Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  154. DIAZ-FEIJOO B , Perez-Benavente MA, Cabrera-Diaz S, Gil-Moreno A, et al
    Change in clinical management of sentinel lymph node location in early stage cervical cancer The role of SPECT/CT.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  155. TORNESELLO ML , Losito S, Benincasa G, Fulciniti F, et al
    Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  156. HOU J , Goldberg GL, Qualls CR, Kuo DY, et al
    Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): A pooled analysis.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  157. CABRERA S , Gil-Moreno A
    Micrometastases in para-aortic lymph nodes in advanced cervical cancer patients - Are a true predictor of recurrence at this level?
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  158. LIM JW , Ashing-Giwa KT
    Examining the effect of minority status and neighborhood characteristics on cervical cancer survival outcomes.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  159. YAN X , Li G, Shang H, Wang G, et al
    Twelve-year experience with laparoscopic radical hysterectomy and pelvic lymphadenectomy in cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  160. SONG EL , Hou YP, Yu SP, Chen SG, et al
    EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  161. LEE YY , Choi CH, Kim TJ, Lee JW, et al
    A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  162. BURGER EA , Kornor H, Klemp M, Lauvrak V, et al
    HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  163. GAFFNEY DK , Soisson AP
    Simple or complex: optimal therapy for cancer of the cervix.
    Gynecol Oncol. 2010;119:401-3.
    PubMed     Text format     Related articles   



  164. DING T , Wang X, Ye F, Cheng X, et al
    Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women.
    Gynecol Oncol. 2010;119:436-43.
    PubMed     Text format     Related articles    Abstract available



  165. PLOTTI F , Zullo MA, Montera R, Pierluigi BP, et al
    Bladder function after laparoscopic nerve-sparing radical hysterectomy.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



    November 2010
  166. CHUNG HH , Kim JW, Han KH, Eo JS, et al
    Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  167. CHARLES-EDWARDS E , Morgan V, Attygalle AD, Giles SL, et al
    Endovaginal magnetic resonance imaging of stage 1A/1B cervical cancer with A T2- and diffusion-weighted magnetic resonance technique: Effect of lesion size and previous cone biopsy on tumor detectability.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  168. PARK JS , Jeon EK, Chun SH, Won HS, et al
    ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  169. EIRIKSSON L , Covens A
    Conservative surgery for early stage cervical cancer: who should we offer it to?
    Gynecol Oncol. 2010;119:173-4.
    PubMed     Text format     Related articles   



  170. HERZOG TJ , Huh WK, Einstein MH
    How does public policy impact cervical screening and vaccination strategies?
    Gynecol Oncol. 2010;119:175-80.
    PubMed     Text format     Related articles    Abstract available



  171. LIM EH , Ng SL, Li JL, Chang AR, et al
    Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.
    Gynecol Oncol. 2010;119:225-31.
    PubMed     Text format     Related articles    Abstract available



  172. KIM MK , Kim JW, Kim MA, Kim HS, et al
    Feasibility of less radical surgery for superficially invasive carcinoma of the cervix.
    Gynecol Oncol. 2010;119:187-91.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  173. KIRSCHNER B , Poll S, Rygaard C, Wahlin A, et al
    Screening history in women with cervical cancer in a Danish population-based screening program.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  174. LI Y , Zeng WJ, Ye F, Wang XY, et al
    Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  175. LIAO CJ , Wu TI, Huang YH, Chang TC, et al
    Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  176. MABUCHI S , Okazawa M, Isohashi F, Ohta Y, et al
    Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  177. COQUILLARD G , Palao B, Patterson BK
    Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  178. LI JH , Xiao X, Zhang YN, Wang YM, et al
    MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  179. ZENG WJ , Li Y, Fei HL, Cheng XD, et al
    The value of p16ink4a expression by fluorescence in situ hybridization in triage for high risk HPV positive in cervical cancer screening.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  180. REIMERS LL , Sotardi S, Daniel D, Chiu LG, et al
    Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women.
    Gynecol Oncol. 2010;119:92-7.
    PubMed     Text format     Related articles    Abstract available



  181. NAKAMURA K , Okumura Y, Kodama J, Hongo A, et al
    The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
    Gynecol Oncol. 2010;119:81-6.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  182. RANDALL LM , Monk BJ, Moon J, Parker R, et al
    Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: A Southwest Oncology Group Study.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  183. CELLA D , Huang HQ, Monk BJ, Wenzel L, et al
    Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  184. ZAND B , Euscher ED, Soliman PT, Schmeler KM, et al
    Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  185. JUNG DC , Kim MK, Kang S, Seo SS, et al
    Identification of a patient group at low risk for parametrial invasion in early-stage cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  186. MARTINEZ A , Zerdoud S, Mery E, Bouissou E, et al
    Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  187. FERRANDINA G , Margariti PA, Smaniotto D, Petrillo M, et al
    Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  188. CARTER J , Sonoda Y, Baser RE, Raviv L, et al
    A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  189. GHIA AJ , Neeley ES, Gaffney DK
    Postoperative radiotherapy use and patterns of care analysis for node positive or parametria positive cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  190. SIEGEL EM , Salemi JL, Villa LL, Ferenczy A, et al
    Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia.
    Gynecol Oncol. 2010;118:289-94.
    PubMed     Text format     Related articles    Abstract available



  191. NUNOBIKI O , Ueda M, Yamamoto M, Toji E, et al
    MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis.
    Gynecol Oncol. 2010;118:258-61.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  192. KIM YH , Kim MA, Park IA, Park WY, et al
    VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  193. DITTO A , Martinelli F, Hanozet F, Reato C, et al
    Class III NSRH: Oncological outcome in 170 cervical cancer patients.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  194. VIJAYARAGHAVAN A , Efrusy MB, Goodman KA, Santas CC, et al
    Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  195. MATSUMURA M , Takeshima N, Ota T, Omatsu K, et al
    Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer-Irinotecan and platinum chemotherapy.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  196. HAZEWINKEL MH , Burger MP, Roovers JP
    Long-term cervical cancer survivors suffer from pelvic floor symptoms.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  197. SMITH AL , Frumovitz M, Schmeler KM, Reis RD, et al
    Conservative surgery in early-stage cervical cancer: What percentage of patients may be eligible for conization and lymphadenectomy?
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  198. LEITAO MM JR , Byrum GV 3rd, Abu-Rustum NR, Brown CL, et al
    Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  199. KIM HS , Kim JY, Park NH, Kim K, et al
    Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  200. KAVALLARIS A , Hornemann A, Chalvatzas N, Luedders D, et al
    Laparoscopic nerve-sparing radical hysterectomy: Description of the technique and patients' outcome.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  201. KUPPERMANN M , Melnikow J, Slee C, Tancredi DJ, et al
    Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions.
    Gynecol Oncol. 2010;118:108-15.
    PubMed     Text format     Related articles    Abstract available



  202. BANSAL S , Lewin SN, Burke WM, Deutsch I, et al
    Sarcoma of the cervix: natural history and outcomes.
    Gynecol Oncol. 2010;118:134-8.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  203. LIANG Z , Chen Y, Xu H, Li Y, et al
    Laparoscopic nerve-sparing radical hysterectomy with fascia space dissection technique for cervical cancer: Description of technique and outcomes.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  204. MARTINEZ A , Mery E, Ferron G, Querleu D, et al
    Incidence of micrometastases in histologically negative para-aortic lymph nodes in advanced cervical cancer patients.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  205. FERRANDINA G , Marcellusi A, Mennini FS, Petrillo M, et al
    Hospital costs incurred by the Italian National Health Service for invasive cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  206. RAHIMIFAR S , Erfani N, Sarraf Z, Ghaderi A, et al
    ctla-4 gene variations may influence cervical cancer susceptibility.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  207. MARKMAN M
    Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  208. PLOTTI F , Calcagno M, Sansone M, Angioli R, et al
    Long-term cervical cancer survivors suffer from pelvic floor symptoms.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



    June 2010
  209. LEE YY , Lee JW, Park HS, Song TJ, et al
    Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  210. PLOTTI F , Sansone M, Di Donato V, Angioli R, et al
    Late morbidity following nerve-sparing radical hysterectomy.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  211. LEVENBACK C
    New or not? Difficulties recognizing innovation.
    Gynecol Oncol. 2010;117:399-400.
    PubMed     Text format     Related articles   



  212. YEASMIN S , Nakayama K, Rahman MT, Rahman M, et al
    Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes.
    Gynecol Oncol. 2010;117:409-16.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  213. MACCHIA G , Ferrandina G, Deodato F, Ruggieri V, et al
    Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: Results of a phase I study (LARA-CC-1).
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  214. EINSTEIN MH , Martens MG, Garcia FA, Ferris DG, et al
    Clinical validation of the Cervista(R) HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  215. FAVERO G , Chiantera V, Oleszczuk A, Galotta V, et al
    Invasive cervical cancer during pregnancy: Laparoscopic nodal evaluation before oncologic treatment delay.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  216. CIBULA D , Abu-Rustum NR
    Classification system for pelvic lymphadenectomy in cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  217. HOFFMANN C , Bachran C, Stanke J, Elezkurtaj S, et al
    Creation and characterization of a xenograft model for human cervical cancer.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  218. STANLEY M
    Pathology and epidemiology of HPV infection in females.
    Gynecol Oncol. 2010;117.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  219. HORN LC , Hentschel B, Einenkel J
    Topographic distribution of pelvic lymph node metastases in cervical cancer patients with FIGO stages IB1 to IIB [Cibula D, Abu-Rustum NR. Pelvic lymphadenectomy in cervical cancer-surgical anatomy and proposal for a new classification system. Gynecol
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  220. SJOEBORG KD , Trope A, Lie AK, Jonassen CM, et al
    HPV genotype distribution according to severity of cervical neoplasia.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  221. ASHING-GIWA KT , Lim JW, Tang J
    Surviving cervical cancer: Does health-related quality of life influence survival?
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  222. GORDON AN , Schimp VL
    Re: Radical abdominal trachelectomy for (microscopic) stage IB1 cervical cancer at 15-week gestation.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  223. EN-LIN S , Sheng-Guo C, Hua-Qiao W
    The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  224. DEL MISTRO A , Frayle-Salamanca H, Trevisan R, Matteucci M, et al
    Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.
    Gynecol Oncol. 2010;117:77-81.
    PubMed     Text format     Related articles    Abstract available



  225. LIN JT , Shih SC, Chang TH, Chang CS, et al
    Docetaxel, carboplatin and 5-fluorouracil (TCF) chemotherapy in patients with unresectable metastatic carcinoma of cervix.
    Gynecol Oncol. 2010;117:65-9.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  226. INABA T , Ino K, Kajiyama H, Shibata K, et al
    Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  227. DOWNS LS JR , Scarinci I, Einstein MH, Collins Y, et al
    Overcoming the barriers to HPV vaccination in high-risk populations in the US.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  228. HOCKEL M , Kahn T, Einenkel J, Manthey N, et al
    Local spread of cervical cancer revisited: A clinical and pathological pattern analysis.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  229. FABBRO M , Gladieff L, Guichard F, El Demery M, et al
    Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  230. PHIPPEN NT , Lowery WJ, Leath CA 3rd, Kost ER, et al
    Epithelioid trophoblastic tumor masquerading as invasive squamous cell carcinoma of the cervix after an ectopic pregnancy.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



  231. QUINT KD , de Koning MN, van Doorn LJ, Quint WG, et al
    HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  232. CHAO FY , Chao A, Huang CC, Hsueh S, et al
    Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  233. PIERALLI A , Bussani C, Andersson KL, Mattei A, et al
    Appendix to: "PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO(2) conization for high-grade cervical intraepithelial neoplasia".
    Gynecol Oncol. 2010;116:586-7.
    PubMed     Text format     Related articles   



  234. DEL PRIORE G , Gudipudi DK, Montemarano N, Restivo AM, et al
    Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.
    Gynecol Oncol. 2010;116:464-7.
    PubMed     Text format     Related articles    Abstract available



  235. PAVLAKIS K , Messini I, Yiannou P, Chrissanthakis D, et al
    A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.
    Gynecol Oncol. 2010;116:468-72.
    PubMed     Text format     Related articles    Abstract available



  236. NUGENT EK , Case AS, Hoff JT, Zighelboim I, et al
    Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
    Gynecol Oncol. 2010;116:438-41.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  237. SERT MB
    Comparison between robot-assisted laparoscopic radical hysterectomy (RRH) and abdominal radical hysterectomy (ARH): A case control study from EIO/Milan.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles   



    January 2010
  238. PANDIT-TASKAR N , Gemignani ML, Lyall A, Larson SM, et al
    Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



    December 2009
  239. SKRET-MAGIERLO J , Narog M, Kruczek A, Kluza R, et al
    Radical hysterectomy during the transition period from traditional to nerve-sparing technique.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available



    November 2009
  240. NEZHAT F , Cho J, Chuang L
    Response to "A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy"
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles   



  241. CIBULA D , Velechovska P, Slama J, Fischerova D, et al
    Late morbidity following nerve-sparing radical hysterectomy.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available



  242. MCKENZIE ND , Kobetz EN, Hnatyszyn J, Twiggs LB, et al
    Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available



    July 2009
  243. HALL JB
    Letter to the Editor regarding "A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy"
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: